TIANXIN PHARMA(SH:603235)2024-05-28 08:19Group 1: Strategic Planning and Development - In 2024, the company will focus on deepening its core business and embracing changes while ensuring steady progress [1] - The company aims to enhance refined management capabilities and optimize product competitiveness by improving overall management and coordinating various functional units [2] - The company plans to solidify safety and environmental foundations to promote sustainable development through improved safety management systems and new technology adoption [2] Group 2: Product Development and Market Position - The company will accelerate new product launches and achieve large-scale production by increasing R&D efforts and leveraging efficient industrial platforms [3] - The company is a significant supplier in the global B vitamin market, holding leading market shares in products like Vitamin B6 and B1, with biotin and folic acid ranking first in the industry [4] Group 3: Financial Performance and Share Buyback - As of April 2024, the company has repurchased 1,368,268 shares, accounting for 0.3125% of the total share capital, with a total expenditure of 28,417,490.56 yuan [5] - The maximum repurchase price was 22.61 yuan per share, and the minimum was 19.17 yuan per share [5] Group 4: Industry Response and Future Outlook - The company will closely monitor the operational dynamics of feed manufacturers and respond promptly to customer needs, especially in light of rising pig prices benefiting the feed industry [6]